Your browser doesn't support javascript.
loading
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer.
Lin, J J; Liu, S V; McCoach, C E; Zhu, V W; Tan, A C; Yoda, S; Peterson, J; Do, A; Prutisto-Chang, K; Dagogo-Jack, I; Sequist, L V; Wirth, L J; Lennerz, J K; Hata, A N; Mino-Kenudson, M; Nardi, V; Ou, S-H I; Tan, D S-W; Gainor, J F.
Afiliación
  • Lin JJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Liu SV; Department of Medicine, Georgetown University, Washington, USA.
  • McCoach CE; Department of Medicine, University of California San Francisco, San Francisco, USA.
  • Zhu VW; Department of Medicine, University of California, Irvine, USA.
  • Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Yoda S; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Peterson J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Do A; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Prutisto-Chang K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Dagogo-Jack I; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Sequist LV; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Wirth LJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Lennerz JK; Harvard Medical School, Boston, USA; Department of Pathology, Massachusetts General Hospital, Boston, USA.
  • Hata AN; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Mino-Kenudson M; Harvard Medical School, Boston, USA; Department of Pathology, Massachusetts General Hospital, Boston, USA.
  • Nardi V; Harvard Medical School, Boston, USA; Department of Pathology, Massachusetts General Hospital, Boston, USA.
  • Ou SI; Department of Medicine, University of California, Irvine, USA.
  • Tan DS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA. Electronic address: jgainor@mgh.harvard.edu.
Ann Oncol ; 31(12): 1725-1733, 2020 12.
Article en En | MEDLINE | ID: mdl-33007380
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos